Table 2.
Phenotype tests for mesenchymal stem cells and known MSC phenotypic characteristics
| Phenotype test | Known MSC phenotype | Method(s) used | Reference(s) |
|---|---|---|---|
| Colony formation | Will form fibroblastic colonies after isolation | CFU-F assay | 22, 44 |
| Immunophenotype | CD11−, CD14−, CD18−, CD31−, CD34−, CD40−, CD45−, CD56−, CD80−, CD86−, MHCII−, CD29+, CD44+, CD71+, CD73+, CD90+, CD105+, CD106+, CD120a+, CD124, CD166+, Stro-1+, ICAM-1+, MHCI+ | FACS | 45, 46 |
| In vitro multipotency | Will differentiate down multiple pathways: Osteogenic Chondrogenic Adipogenic |
Induction via specialized media | 47 |
| Ectopic marrow formation | Will form ectopic bone marrow in the presence of bone minerals | Subcutaneous transplantation, kidney capsule transplantation, diffusion chamber transplantation | 48, 49 |
| In vivo multipotency | Subset of MSCs, termed MAPCs, are capable of contributing to all somatic cell types in mice | Blastocyst transplantation | 50 |
Abbreviations: CFU-F, colony forming units-fibroblastic; FACS, fluorescent activated cell sorting; MAPC, multipotent adult progenitor cell.